BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32594465)

  • 1. Oral appliances in the treatment of oromandibular dystonia: a systematic review.
    De Meyer M; Vereecke L; Bottenberg P; Jacquet W; Sims AB; Santens P
    Acta Neurol Belg; 2020 Aug; 120(4):831-836. PubMed ID: 32594465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis.
    Dadgardoust PD; Rosales RL; Asuncion RM; Dressler D
    J Neural Transm (Vienna); 2019 Feb; 126(2):141-148. PubMed ID: 30604200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of botulinum toxin type A in neuro-ORL].
    Périé S; Lacau St Guily J
    Ann Readapt Med Phys; 2003 Jul; 46(6):375-9. PubMed ID: 12928145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Botulinum Toxin Therapy on Health-Related Quality of Life Evaluated by the Oromandibular Dystonia Rating Scale.
    Yoshida K
    Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia.
    Scorr LM; Silver MR; Hanfelt J; Sperin E; Freeman A; Jinnah HA; Factor SA
    Neurotherapeutics; 2018 Apr; 15(2):452-458. PubMed ID: 29542022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oromandibular dystonia: long-term management with botulinum toxin.
    Sinclair CF; Gurey LE; Blitzer A
    Laryngoscope; 2013 Dec; 123(12):3078-83. PubMed ID: 24122897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oromandibular dystonia, mental distress and oro-facial dysfunction-A follow-up 8-10 years after start of treatment with botulinum toxin.
    Bakke M; Baram S; Dalager T; Biernat HB; Møller E
    J Oral Rehabil; 2019 May; 46(5):441-449. PubMed ID: 30664806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory Open Jaw Oromandibular Tardive Dystonia with a Sensory Trick, Treated with Botulinum Toxin: A Case Report.
    Shalash AS; Abushouk AI; Elsherbeny MY; Elrassas H; Kamel T
    Neurol India; 2019; 67(4):1110-1111. PubMed ID: 31512647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up.
    Tan EK; Jankovic J
    Neurology; 1999 Dec; 53(9):2102-7. PubMed ID: 10599789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
    Yoshida K
    Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition].
    Budrewicz S; Koszewicz M; Góral M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():55-60. PubMed ID: 15098332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia.
    Adler CH; Factor SA; Brin M; Sethi KD
    Mov Disord; 2002 Jan; 17(1):158-61. PubMed ID: 11835455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-Onset Focal Task Specific Oromandibular Dystonia in Association with Quran Recitation: A Case Series.
    Al-Hashel JY; Soliman DY; Ismail II
    Tremor Other Hyperkinet Mov (N Y); 2024; 14():3. PubMed ID: 38222897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System.
    Yoshida K
    Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oromandibular dystonia and hormonal factors: twelve years follow-up of a case report.
    Michelotti A; Silva R; Paduano S; Cimino R; Farella M
    J Oral Rehabil; 2009 Dec; 36(12):916-21. PubMed ID: 19840357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review of botulinum toxin treatment for oromandibular dystonia.
    Comella CL
    Toxicon; 2018 Jun; 147():96-99. PubMed ID: 29453996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-Guided OnabotulinumtoxinA Injections to Treat Oromandibular Dystonia in Cerebral Palsy.
    Reyes FI; Shoval HA; Tenaglia A; Kim H
    Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oromandibular Dystonia: Clinical and Demographic Data from Eight-Two Patients.
    Balal M; Demirkiran M
    Tremor Other Hyperkinet Mov (N Y); 2023; 13():3. PubMed ID: 36789171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin in a task-specific oromandibular dystonia in a bingo caller.
    Díaz-Sánchez M; Martínez-Castrillo JC
    J Neurol; 2008 Jun; 255(6):942-3. PubMed ID: 18481036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.